1 Min Read
Jan 22 (Reuters) - Astrazeneca Plc
* Marketing authorisation application for gout treatment Lesinurad accepted by European Medicines Agency Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.